Skip to content

The effect of a single bolus dose of intravenous dexmedetomidine given intraoperatively on the remifentanil-reduced postoperative hyperalgesia.

The effect of a single bolus dose of intravenous dexmedetomidine given intraoperatively on the remifentanil-reduced postoperative hyperalgesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018373
Enrollment
Unknown
Registered
2018-09-14
Start date
2018-10-08
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the remifentanil-reduced postoperative hyperalgesia.

Interventions

Group C:a single bolus of saline given 30min before the end of the surgery
Group LD:a single bolus of 0.2ug/kg dexmedetomidine given 30min before the end of the surgery
Group HD:a single bolus of 0.5ug/kg dexmedetomidine given 30min before the end of the surgery

Sponsors

Sun Yat-Sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. ASA physical status I or II; 2. Patients aged 20~75 years; 3. Patients undergoing thyroidectom1.

Exclusion criteria

Exclusion criteria: 1. A history of anaesthetic allergy; 2. Mental or neurological disease; 3. Liver or renal dysfunction; 4. BMI > 30kg/m2; 5. Pregnant women; 6. A history of acute or chronic painor undergoing pain treatment; 7. Drugs or alcohol abuse; 8. Cardiovascular disease; 9. Arhythmia.

Design outcomes

Primary

MeasureTime frame
The mechanical pain threshold on the peri-incisional area 30min after surgery;

Secondary

MeasureTime frame
the other mechanical pain threshold on the peri-incisional area or the non-dominant Forearm;Postoperative pain intensity (NRS);the incidence of moderate or severe pain (NRS>4);Total consumption of analgesics 48hr after surgery;time to extubation;length of stay;

Countries

China

Contacts

Public ContactLonghui Cao

Sun Yat-Sen University Cancer Center

clhforever@hotmail.com+86 13826092036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026